• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外泪液补充系统的设计与开发。

Design and development of an in vitro tear replenishment system.

作者信息

Mohammadi Saman, Postnikoff Cameron, Wright Ann M, Gorbet Maud

机构信息

Systems Design Engineering, University of Waterloo, 200 University Ave., Waterloo, ON, Canada.

出版信息

Ann Biomed Eng. 2014 Sep;42(9):1923-31. doi: 10.1007/s10439-014-1045-1. Epub 2014 Jun 13.

DOI:10.1007/s10439-014-1045-1
PMID:24923378
Abstract

Understanding the cellular and molecular mechanisms of the corneal tissue and translating them into effective therapies requires organotypic culture systems that can better model the physiological conditions of the front of the eye. Human corneal in vitro models currently exist, however, the lack of tear replenishment limits corneal in vitro models' ability to accurately simulate the physiological environment of the human cornea. The tear replenishment system (TRS), a micro-fluidic device, was developed to mimic the in vivo tear replenishment in the human eye in an in vitro corneal model. The TRS is capable of generating adjustable intermittent flow from 0.1 µL in every cycle. The TRS is a sterilizable device that is designed to fit standard 6-well cell culture plates. Experiments with the corneal models demonstrated that exposure to the TRS did not damage the integrity of the stratified cell culture. Contact lenses "worn" by the in vitro corneal model also remained moist at all times and the cytotoxicity of BAK could also be verified using this model. These in vitro results confirmed that the TRS presents novel avenues to assess lens-solution biocompatibility and drug delivery systems in a physiologically relevant milieu.

摘要

了解角膜组织的细胞和分子机制并将其转化为有效的治疗方法,需要能够更好地模拟眼前部生理状况的器官型培养系统。目前存在人角膜体外模型,然而,缺乏泪液补充限制了角膜体外模型准确模拟人角膜生理环境的能力。泪液补充系统(TRS)是一种微流控装置,旨在在体外角膜模型中模拟人眼体内的泪液补充。TRS能够在每个周期产生0.1微升的可调间歇性流动。TRS是一种可消毒的装置,设计用于适配标准的6孔细胞培养板。角膜模型实验表明,暴露于TRS不会损害分层细胞培养的完整性。体外角膜模型“佩戴”的隐形眼镜也始终保持湿润,并且使用该模型还可以验证BAK的细胞毒性。这些体外结果证实,TRS为在生理相关环境中评估镜片-溶液生物相容性和药物递送系统提供了新途径。

相似文献

1
Design and development of an in vitro tear replenishment system.体外泪液补充系统的设计与开发。
Ann Biomed Eng. 2014 Sep;42(9):1923-31. doi: 10.1007/s10439-014-1045-1. Epub 2014 Jun 13.
2
In vitro assessment of medical device toxicity: interactions of benzalkonium chloride with silicone-containing and p-hema-containing hydrogel contact lens materials.医疗器械毒性的体外评估:苯扎氯铵与含硅和含甲基丙烯酸羟乙酯水凝胶隐形眼镜材料的相互作用
Eye Contact Lens. 2007 Jan;33(1):26-37. doi: 10.1097/01.icl.0000229775.17844.3f.
3
Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells.在完全限定的人角膜上皮细胞培养模型中天然泪液替代物的毒性
Invest Ophthalmol Vis Sci. 2001 Apr;42(5):948-56.
4
Lipidomic analysis of epithelial corneal cells following hyperosmolarity and benzalkonium chloride exposure: New insights in dry eye disease.高渗和苯扎氯铵处理后上皮角膜细胞的脂质组学分析:干眼症的新见解。
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Sep;1865(9):158728. doi: 10.1016/j.bbalip.2020.158728. Epub 2020 May 11.
5
Surface chemistry study of the interactions of benzalkonium chloride with films of meibum, corneal cells lipids, and whole tears.表面化学研究苯扎氯铵与脂类、角膜细胞脂质和全泪液的相互作用。
Invest Ophthalmol Vis Sci. 2011 Jun 28;52(7):4645-54. doi: 10.1167/iovs.10-6271.
6
Development of a curved, stratified, in vitro model to assess ocular biocompatibility.开发一种用于评估眼部生物相容性的弯曲、分层、体外模型。
PLoS One. 2014 May 16;9(5):e96448. doi: 10.1371/journal.pone.0096448. eCollection 2014.
7
In vitro and in vivo evaluation of a preservative-free cationic emulsion of latanoprost in corneal wound healing models.在角膜创伤愈合模型中评估一种不含防腐剂的拉坦前列素阳离子乳剂的体内外效果。
Cornea. 2012 Nov;31(11):1319-29. doi: 10.1097/ICO.0b013e318255a7f8.
8
Feasibility of corneal drug delivery of cysteamine using vitamin E modified silicone hydrogel contact lenses.使用维生素E修饰的硅水凝胶隐形眼镜进行半胱胺角膜给药的可行性。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):531-40. doi: 10.1016/j.ejpb.2013.04.017. Epub 2013 May 9.
9
[Corneal protection in contact lens users].[隐形眼镜使用者的角膜保护]
Vestn Oftalmol. 2014 Mar-Apr;130(2):59-64, 66-7.
10
Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells.苯扎氯铵和聚季铵盐保存的青光眼联合用药对培养的人眼表面细胞的影响。
Adv Ther. 2011 Jun;28(6):501-10. doi: 10.1007/s12325-011-0029-x. Epub 2011 May 16.

引用本文的文献

1
In vitro tear replenishment system: assessing drug delivery from contact lens biomaterials through corneal epithelial monolayer and multilayer under replenishment conditions.体外泪液补充系统:评估在补充条件下通过角膜上皮单层和多层从隐形眼镜生物材料中进行药物递送的情况。
Drug Deliv Transl Res. 2024 Dec 5. doi: 10.1007/s13346-024-01746-z.
2
Differential Deposition of Fluorescently Tagged Cholesterol on Commercial Contact Lenses Using a Novel In Vitro Eye Model.使用新型体外眼模型研究荧光标记胆固醇在商用隐形眼镜上的差异沉积
Transl Vis Sci Technol. 2018 Apr 5;7(2):18. doi: 10.1167/tvst.7.2.18. eCollection 2018 Apr.
3
3D Microfabricated Scaffolds and Microfluidic Devices for Ocular Surface Replacement: a Review.
3D 微制造支架和微流控装置在眼表面置换中的应用:综述。
Stem Cell Rev Rep. 2017 Jun;13(3):430-441. doi: 10.1007/s12015-017-9740-6.
4
Development of an In Vitro Ocular Platform to Test Contact Lenses.用于测试隐形眼镜的体外眼部平台的开发。
J Vis Exp. 2016 Apr 6(110):e53907. doi: 10.3791/53907.